Bevacizumab for newly diagnosed glioblastoma
- PMID: 24849089
- DOI: 10.1056/NEJMc1403303
Bevacizumab for newly diagnosed glioblastoma
Comment in
-
Bevacizumab for newly diagnosed glioblastoma.N Engl J Med. 2014 May 22;370(21):2048-9. doi: 10.1056/NEJMc1403303. N Engl J Med. 2014. PMID: 24849088 No abstract available.
-
Bevacizumab for newly diagnosed glioblastoma.N Engl J Med. 2014 May 22;370(21):2049. doi: 10.1056/NEJMc1403303. N Engl J Med. 2014. PMID: 24860870 No abstract available.
Comment on
-
A randomized trial of bevacizumab for newly diagnosed glioblastoma.N Engl J Med. 2014 Feb 20;370(8):699-708. doi: 10.1056/NEJMoa1308573. N Engl J Med. 2014. PMID: 24552317 Free PMC article. Clinical Trial.
-
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.N Engl J Med. 2014 Feb 20;370(8):709-22. doi: 10.1056/NEJMoa1308345. N Engl J Med. 2014. PMID: 24552318 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical